Pimecrolimus goes pharmacogenetic

Previewing what may become routine in a few years, researchers have used genetic profiling to evaluate efficacy and adverse effects of a drug undergoing clinical trials for the treatment of psoriasis.

Related Videos
Related Content

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Lauren Miller, PA-C, Discusses SDPA and Updates in Dermatology

March 23rd 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Lauren Miller, PA-C, Discusses SDPA and Updates in Dermatology

March 23rd 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Lauren Miller, PA-C, Discusses SDPA and Updates in Dermatology

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.